Tim Heisse

32PUBLICATIONS
58CO-AUTHORS
PharmacogenomicsEconometric and statistical methodsNanotoxicology, health and safetyBehavioural epidemiologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 02, 2026
Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.

|Apr 22, 2026
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials.

|Feb 23, 2026
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.

Jennifer Leohr, Oliver Klein, Tim Heise

|Mar 17, 2025
Biosimilar insulins: Narrative review of the regulatory framework and registration studies.

Tim Heise, J Hans DeVries

|Jan 06, 2025
Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Kieren J Mather, Andrea Mari, Govinda Weerakkody

|Aug 07, 2024
ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetes.

Grit Andersen, Rosy Eloy, Tim Heise

Pageof 6

Frequent Collaborators

10 joint publications

J Hans DeVries

7 joint publications

Eric Zijlstra

4 joint publications

Axel Haupt

4 joint publications

Grit Andersen